Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2006
11/22/2006EP1724357A1 A process for producing astaxanthin-containing lipids
11/22/2006EP1724355A2 Transgenic plants containing molecular decoys that alter protein content therein
11/22/2006EP1724354A2 Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy
11/22/2006EP1724352A2 Specific nucleic acids and polypeptide from pathogenic strains of Neisseria
11/22/2006EP1724349A1 TIE Ligand Homologues
11/22/2006EP1724344A1 Process for producing amino acid
11/22/2006EP1724337A1 Method for preserving xanthophyll in algal cells
11/22/2006EP1724336A1 Method for improving the drying and product quality of microorganisms
11/22/2006EP1723950A2 Method of treating dopaminergic gaba-nergic disorders
11/22/2006EP1723230A1 Altered expression in filamentous fungi
11/22/2006EP1506309B1 Plating media
11/22/2006EP1454905B1 Novel substance fki-1083 and process for producing the same
11/22/2006EP1360306B1 Dna sequence of the enzyme phospholipase a1 of ciliate tetrahymena, and the use of the same
11/22/2006EP1173465B1 Novel human voltage-gated potassium channel
11/22/2006EP1142988B1 Novel microorganism and use thereof
11/22/2006EP1078054B1 Monomeric mp52/gdf-5 with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
11/22/2006EP0999273B1 HUMAN GENE RecQ4 ENCODING HELICASE
11/22/2006EP0885296B1 An enzyme with galactanase activity
11/22/2006EP0839185B1 Screening methods for enzymes and enzyme kits
11/22/2006CN1867677A Process for preparing enantiomer-enriched alpha-hydroxycarboxylic acids and amides
11/22/2006CN1867676A Process for producing scyllo-inositol
11/22/2006CN1867664A Production of tacrolimus (fk-506) using new streptomyces species
11/22/2006CN1867662A Apparatus for ultrasonic microbial disruption
11/22/2006CN1867588A Product comprising a c4bp core protein and a monomeric antigen, and its use
11/22/2006CN1867258A Stable liquid probiotic composition, preparation and applications thereof
11/22/2006CN1865450A Fatty acid extract of Antrodiacamphorata mycelium and its uses
11/22/2006CN1865431A 1,3-glyceric acid engineered bacteria, its construction and method for producing 1,3-glyceric acid using the said bacteria
11/22/2006CN1865430A Engineered bacteria Pichia pastoris for high yield of insulinotropic hormone and its construction method
11/22/2006CN1865429A Low temperature conservation method for Chinese mushroom strain
11/22/2006CN1864516A A method for preparing feedstuff addictive from yeast
11/22/2006CN1864491A A method for preparing biological control agent of Verticillium spp.
11/22/2006CN1285827C Microbe trielement compound oil-displacement method and microbe trielement compound oil-displacement agent
11/22/2006CN1285723C Culture medium for promoting bacteria fast reproduction
11/22/2006CN1285722C Peptides natural microbial antiseptic agent producing strain, its use and preparation method for antiseptic agent
11/22/2006CN1285721C Gibberella gene engineering bacterium and its preparation and application
11/22/2006CN1285720C Cordyceps vegetative stage solid fermentation technology
11/22/2006CN1285381C Chemokine mutants in treatment of multiple sclerosis
11/21/2006US7138568 Expression vector coding insecticidal protein for use in the transformation and generation of moth resistant leafy plants
11/21/2006US7138515 Translational activity-promoting higher-order structure
11/21/2006US7138513 Genes encoding for genetic stability, gene expression and folding proteins
11/21/2006US7138512 Gene SHINC-2 and diagnostic and therapeutic uses thereof
11/21/2006US7138509 GANP protein
11/21/2006US7138508 Inhibitor protein of the wnt signal pathway
11/21/2006US7138501 Antibodies that immunospecifically bind BLyS
11/21/2006US7138499 antibody that binds to a peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily
11/21/2006US7138497 Genetic engineering; crosslinking polypeptide on carrier
11/21/2006US7138494 Comprises amino acid transport protein (ASC-1) for regulating NMDA-type glutamic acid receptor; treatment of nervous system disorders; antiproliferative agents; gene expression inhibition
11/21/2006US7138492 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
11/21/2006US7138480 3-Hydroxycarboxylic acid production and use in branched polymers
11/21/2006US7138380 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
11/21/2006US7138374 Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137
11/21/2006US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006US7138273 Screening for genes which trigger hypersensitive response in tobacco plants in presence of ubiquitous Phytophthora infestans elicitor; horticulture
11/21/2006US7138267 Methods and compositions for amplifying DNA clone copy number
11/21/2006US7138266 Bacterial strain of Escherichia coli BKIIM B-3996 as the producer of L-threonine
11/21/2006US7138263 Endoglucanase enzyme NCE5 and cellulase preparations containing the same
11/21/2006US7138260 Animal feed composition containing a thermotolerant phytase which retains at least 40% activity after 30 minutes at 60 degrees C. and has a specific activity of greater than 200 U/mg at pH 4.5 and 37 degrees C
11/21/2006US7138258 polypeptide that has alpha -2,3-sialyltransferase activity; involved in synthesis of lipooligosaccharides including gangliosides and ganglioside mimics; campylobacter jejuni (C. jejuni)
11/21/2006US7138252 For prevention/treatment of allergies/cancer/drug addiction/poisoning
11/21/2006US7138243 NTB-A, a surface molecule involved in natural killer cells activity
11/21/2006US7138234 Gene involved in CADASIL, method of diagnosis and therapeutic application
11/21/2006US7138126 Modifying wild strain of enteroinvasive Shigella; cannot spread within infected cells and from infected to uninfected cells of the host; vaccines; deactivation by inserting transposon into gene; mutagenizing; genetically engineered by allelic exchange
11/21/2006US7138125 Polypeptide for prevention, therapy of bacteria infections; gramnegative bacteria; therapy for reduced lactation in animals
11/21/2006US7138124 Lipopolysaccharides; forming antibodies; isolation exterior membrane polypeptide
11/21/2006US7138112 Plasmid maintenance system for antigen delivery
11/21/2006CA2199140C Probiotic compositions
11/16/2006WO2006122224A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in pseudomonas aeruginosa
11/16/2006WO2006121895A2 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
11/16/2006WO2006121848A2 Method for the isolation of spiroplasma in mammals
11/16/2006WO2006121755A2 Utilization of fructose in microbial production strains
11/16/2006WO2006121354A1 Fungal material stabilisation
11/16/2006WO2006121350A1 Entomopathogenic fungi and uses thereof
11/16/2006WO2006120770A1 Vital cell-controlling apparatus and vital cell-controlling method
11/16/2006WO2006120579A2 Methods for detecting virulent plasmodium, for evaluating plasmodium virulence, and for screening new drugs employing the 3'utr of plasmodium sub2 and the plasmodium sub2 serine protease
11/16/2006WO2006120278A1 Method of fixing carbon dioxide using a culture of cyanobacteria
11/16/2006WO2006119780A2 New antibiotic-sensitive lactic acid bacteria strains
11/16/2006WO2006046152A3 Methods for heterologous expression of secondary metabolites
11/16/2006WO2006044290A3 Biosynthesis of philoroglucinol and preparation of 1,3-dihydroxybenzene therefrom
11/16/2006US20060260008 vectors, transformed host cells that contain nucleic acid segments that encode the disclosed delta -endotoxin polypeptides; Bacillus thuringiensis cell
11/16/2006US20060260000 Removal of plastid sequences by transiently expressed site-specific recombinases
11/16/2006US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006US20060259247 Apparatus and method for automated protein design
11/16/2006US20060258848 Human antipneumococcal antibodies from non-human animals
11/16/2006US20060258841 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/16/2006US20060258603 Transposon-based targeting system
11/16/2006US20060258596 Antimicrobial agents
11/16/2006US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006US20060258574 Novel compositions and methods for the treatment of psoriasis
11/16/2006US20060258563 Nitrogen Oxide scavenging ability; digesting cytochrome c with restriction enzyme; use in prophylactic and therapeutics, measuring/treating nitrogen oxide concentrations in air, exhaust gas or water
11/16/2006US20060258554 Bgl6 beta-glucosidase and nucleic acids encoding the same
11/16/2006US20060258534 Rhizobium leguminosarum strain and use thereof as plant inoculant
11/16/2006US20060258007 Regulated vectors for selection of cells exhibiting desired phenotypes
11/16/2006US20060257989 Truncated aggrecanase molecules
11/16/2006US20060257984 Hybrid enzymes
11/16/2006US20060257983 Metabolically engineered micro-organisms having reduced production of undesired metabolic products
11/16/2006US20060257981 culturing a microorganism belonging to the species Dactylosporangium, in a nutrient medium and isolating tiacumicin B; antibiotics used for prophylaxis and therapy of bacterial infections
11/16/2006US20060257979 Using recombinant microorganisms in which the open reading frame (ORF) designated ytfQ is enhanced in particular overexpressed; fermentation
11/16/2006US20060257976 Methods and kits for propagating and evolving nucleic acids and proteins
11/16/2006US20060257975 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,